Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Thymic epithelial cells may be related to skin stem cells.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Direct-to-consumer teledermatology effectively treats male hair loss but may increase drug costs and requires monitoring for side effects.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

A young Teckel dog had severe skin issues due to mites, worsened by incorrect treatment, needing specific medications and prevention by not breeding affected dogs.

Telogen effluvium is a type of hair loss that happens when stress or illness causes many hairs to enter the resting phase and fall out.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Emotional Freedom Techniques (EFT) treatment improved seed germination and growth, suggesting mood affects seed viability.

Tabby mutations in mice affect hair follicle development and help study genetic mapping and certain medical conditions.

Mutations in the TSPEAR gene cause a new form of ectodermal dysplasia affecting hair and tooth development.

Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Asynchronous telemedicine for acne treatment is effective and improves access and productivity.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Normal skin results from interactions between EGF and the Tabby mutation.

Exercise-induced particles can slow breast cancer growth by boosting immune response.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Transcutaneous electrical acustimulation helps wounds heal faster in mice.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.